Watson Laboratories Inc. may not launch its copy of Teva Women’s Health Inc.'s Seasonique (levonorgestrel/ethinyl estradiol combination tablets and ethinyl estradiol tablets) while Teva appeals to the U.S. Court of Appeals for the Federal Circuit a lower court’s denial of a preliminary injunction in its patent infringement litigation over the contraceptive pill (Duramed Pharmaceuticals Inc. v. Watson Laboratories Inc., Fed. Cir., 2011-1438, 6/17/11).
In a nonprecedential opinion issued June 17, Judge Pauline Newman of the U.S. Court of Appeals for the Federal Circuit granted Teva’s emergency motion for a temporary injunction. In connection with granting the motion, ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.